Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Leukemia & Lymphoma|June 13, 2022
Clonal hematopoiesis in clinical practice: walking a tightropeFrancesco Tarantini, Cosimo Cumbo, Luisa Anelli, et al.Frontiers in Pharmacology|June 9, 2022
Exploring the Potential of Eltrombopag: Room for More?Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, et al.Tumori|December 27, 2023
Cytisine as a smoking cessation aid: Preliminary observations with a modified therapeutic scheme in real lifePaolo Pozzi, Roberto Boffi, Chiara Veronese, et al.Respiratory Medicine|July 13, 2007
Clara cell 16 protein in COPD sputum: a marker of small airways damage?Fulvio Braido, Anna M Riccio, Laura Guerra, et al.Cancer Management and Research|November 7, 2019
Skin lesions in chronic myeloid leukemia patients during dasatinib treatmentFrancesco Tarantini, Luisa Anelli, Giuseppe Ingravallo, et al.Experimental Hematology & Oncology|December 25, 2021
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosisCosimo Cumbo, Francesco Tarantini, Luisa Anelli, et al.International Journal of Molecular Sciences|February 25, 2023
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?Maria Rosa Conserva, Immacolata Redavid, Luisa Anelli, et al.Leukemia & Lymphoma|July 23, 2024
Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, et al.Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|August 31, 2021
A 57-year-old man with rapidly progressive pulmonary hypertensionFederico Raimondi, Caterina Conti, Luca Novelli, et al.Discover Oncology|July 8, 2026
Leukemic architecture as a framework for risk stratification in NPM1-mutated acute myeloid leukemiaFrancesco Tarantini, Luisa Anelli, Antonella Zagaria, et al.Pageof 4